Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Gene Therapy Development | Whitepapers & Reports

Post-Event Proceedings – Gene Therapy Development & Manufacturing 2023

08 March 2024
Concise and insightful summaries of presentations delivered by prominent thought leaders at Gene Therapy Development & Manufacturing 2023.
Open document in a new tab

Related Resources

Jaguar Gene's JAG201 Therapy Trial for SHANK3 Haploinsufficiency Receives FDA Approval

JAG201 gene replacement therapy available to both child and adult patients is now in Phase I clinical trial.
Read More

Reshaping Genome Editing: Doudna & Charpentier, the Founders of CRISPR/Cas9 and Their Legacy

In 2020 Jennifer Doudna & Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry for discovering the revolutionary gene-editing tool CRISPR/Cas9. This article shines a spotlight on their remarkable achievements and addresses current applications and future opportunities for CRISPR/Cas9.
Read More